Activin A expression in neuroblastoma results in elevated cyclin-dependent kinase inhibitors and decreased vascular endothelial growth factor receptor 2 (VEGFR2) [45,51,65,89,90,143]. The gene discussed is KDR; the disease is neuroblastoma.